MedTrace Logo

GLP-1 Receptor Agonist Use and Incidence of Retained Gastric Food on Endoscopy

NCT05875636 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 260

Last updated 2024-09-19

No results posted yet for this study

Summary

This study will enroll patients ages 18 and over who are in one of the following groups 1) taking a GLP-1 receptor agonist medication 2) not taking a GLP-1 receptor agonist (control group), are undergoing EGS and have appropriately fasted. Study data will be collected in the form of qualitatively observing whether the stomach is empty as expected, or contains solid or clinically relevant liquid contents.

Conditions

  • Gastric Content Aspiration

Interventions

OTHER

Esophagogastroduodenoscopy

All patients will undergo an esophagogastroduodenoscopy per standard of care, as scheduled.

Sponsors & Collaborators

  • Medical University of South Carolina

    lead OTHER

Principal Investigators

  • Phillip R Wilson, M.D. · Medical University of South Carolina

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-21
Primary Completion
2024-08-23
Completion
2024-08-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05875636 on ClinicalTrials.gov